Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -586,454 | -434,172 | -273,156 | -171,082 | -505,488 |
| Depreciation Amortization | 5,843 | 4,317 | 4,052 | 566 | 1,456 |
| Accounts receivable | N/A | N/A | -1,040 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,833 | 1,360 | 13,025 | 1,792 | -735 |
| Other Working Capital | -4,396 | -24,999 | -41,372 | -15,420 | 14,934 |
| Other Operating Activity | 84,240 | 89,455 | 56,013 | 33,379 | 90,119 |
| Operating Cash Flow | $-497,934 | $-364,039 | $-242,478 | $-150,765 | $-399,714 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,246 | -10,710 | -4,248 | -1,961 | -7,518 |
| Purchase Of Investment | -643,275 | -599,438 | -529,934 | -379,291 | -287,852 |
| Sale Of Investment | 477,041 | 408,868 | 238,934 | 99,200 | 249,137 |
| Purchase Sale Intangibles | -35,000 | -35,000 | N/A | N/A | N/A |
| Other Investing Activity | -21,346 | -21,346 | 13,654 | 0 | -6,760 |
| Investing Cash Flow | $-200,826 | $-222,626 | $-281,594 | $-282,052 | $-52,993 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 747,500 | N/A | N/A | N/A | N/A |
| Debt Issued | 456,296 | 772,500 | 772,500 | 747,500 | 550,000 |
| Debt Repayment | -124,119 | -18,108 | -18,108 | N/A | N/A |
| Common Stock Issued | 20,464 | 18,115 | 12,868 | 9,116 | 38,222 |
| Common Stock Repurchased | -266,041 | -263,788 | -119,905 | -112,316 | -124,994 |
| Other Financing Activity | -97,654 | -97,654 | -100,834 | -96,388 | -16,039 |
| Financing Cash Flow | $736,446 | $411,065 | $546,521 | $547,912 | $447,189 |
| Beginning Cash Position | 358,679 | 358,679 | 358,679 | 358,679 | 364,197 |
| End Cash Position | 396,365 | 183,079 | 381,128 | 473,774 | 358,679 |
| Net Cash Flow | $37,686 | $-175,600 | $22,449 | $115,095 | $-5,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -497,934 | -364,039 | -242,478 | -150,765 | -399,714 |
| Capital Expenditure | -13,246 | -10,710 | -4,248 | -1,961 | -7,518 |
| Free Cash Flow | -511,180 | -374,749 | -246,726 | -152,726 | -407,232 |